Overwhelming evidences revealed that the ATX/lysophosphatidate (LPA) signaling axis served key roles in energy metabolism regulation and obesity control, dysregulation of which could cause inflammation and tumorigenesis [24, 25]. Here, ENPP2 is linked to obesity disorder.